Study on abdominal visceral fat reducing action by indigestible dextrin-containing tea beverage - Randomized placebo-controlled double-blind parallel group comparison study
- Conditions
- ot applicable
- Registration Number
- JPRN-UMIN000032508
- Lead Sponsor
- Coca-Cola (Japan) Company, limited Matsutani Chemical Industry co.,ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 140
Not provided
1 Subjects who received medication treatment or surgery due to serious illness or injury within 1 months from the start of this study 2 Subjects who have a history of severe illness and current medical history in the heart, liver, kidney, digestive organs 3 Subjects who medicine for glycometabolism, lipidmetabolism, or reducing high blood pressure 4 Subjects who regularly use over-the-counter medicine, health foods, supplements which are suggested causal relationship from the screening test 5 Pregnant and lactating female, or who wish to get pregnant during the study period 6 Heavy drinkers 7 Individual donated 400 ml of blood within 12weeks or component blood donation 200 ml of blood within 4weeks prior to the study 8 Subjects who are planned to change their life style or maitain irregular life during study period 9 Subjects who cannot follow test sample intake condition by the protocol 10 Subjects already participating in other clinical trials, subjects planning to participate during this examination period 11 Subjects who are ineligible due to physician's judgment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy Visceral fat area
- Secondary Outcome Measures
Name Time Method Efficacy Total fat area, subcutaneous fat area, body weight, BMI, Triglycerides, glycometabolism relation items Safety Side effect incidence,Adverse event incidence, clinical examination items excluding efficacy evaluation items, and physiological examination items excluding efficacy evaluation items